Am J Pathol. 2023 Sep 21. pii: S0002-9440(23)00362-0. [Epub ahead of print]
Juan-Hua Quan,
Fei Fei Gao,
Tian-Zhong Ma,
Wei Ye,
Xiang Gao,
Ming-Zhu Deng,
Lan-Lan Yin,
In-Wook Choi,
Jae-Min Yuk,
Guang-Ho Cha,
Young-Ha Lee,
Jia-Qi Chu.
Toxoplasma gondii infection in pregnant women may cause fetal anomaly; however, the underlying mechanisms remain unclear. Here, we investigated whether T. gondii induces pyroptosis in human placental cells and the underlying mechanisms. Human placental trophoblast (BeWo and HTR-8/SVneo) and amniotic (WISH) cells were infected with T. gondii, and then ROS production, cathepsin B (CatB) release, inflammasome activation, and pyroptosis induction were evaluated. Moreover, the molecular mechanisms of these effects were investigated by treating the cells with ROS scavengers, a CatB inhibitor, or inflammasome-specific siRNA. We found that T. gondii infection induced ROS generation and CatB release into the cytosol in placental cells but decreased mitochondrial membrane potential. T. gondii-infected human placental cells and villi showed NLRP1, NLRP3, NLRC4, and AIM2 inflammasome activation and subsequent pyroptosis induction, as evidenced by increased expression of ASC, cleaved caspase-1, and mature IL-1β and gasdermin D cleavage. In addition to inflammasome activation and pyroptosis induction, adverse pregnancy outcome was revealed in a T. gondii-infected pregnant mouse model. Administration of ROS scavengers, CatB inhibitor, or inflammasome-specific siRNA into T. gondii-infected cells reversed these effects. Collectively, these findings show that T. gondii induces NLRP1/NLRP3/NLRC4/AIM2 inflammasome-dependent caspase-1-mediated pyroptosis via induction of ROS production and CatB activation in placental cells, and this mechanism may play an important role in inducing cell injury in congenital toxoplasmosis.
Keywords: Congenital toxoplasmosis; Human placental cells; Inflammasomes; Pregnant mouse model; Pyroptosis; Toxoplasma gondii